Augmenting antidepressant medication with modular CBT for geriatric generalized anxiety disorder: A pilot study

International Journal of Geriatric Psychiatry

Volumn 26, Issue 8, 2011, Pages 869-875

  Wetherell, Julie Loebach ^a,b   Stoddard, Jill A ^c   White, Kamila S ^d   Kornblith, Sander ^e   Nguyen, Hoang ^a,b   Andreescu, Carmen ^e   Zisook, Sidney ^a,b   Lenze, Eric J ^f  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ALLIANT INTERNATIONAL UNIVERSITY   (United States)

^d UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aged; behavior therapy; cognitive therapy; drug therapy; elderly; psychotherapy; selective serotonin reuptake inhibitor

Indexed keywords

ESCITALOPRAM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE THERAPY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; GENERALIZED ANXIETY DISORDER; HAMILTON ANXIETY SCALE; HUMAN; MALE; PATIENT EDUCATION; PENN STATE WORRY QUESTIONNAIRE; PERSONALIZED MEDICINE; PILOT STUDY; PROBLEM SOLVING; QUESTIONNAIRE; RELAXATION TRAINING; REMISSION; SKILL; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; BEHAVIOR THERAPY; CITALOPRAM; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; HEALTH SERVICES FOR THE AGED; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS;

EID: 79960161948     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2619     Document Type: Article

References (49)

1. Allgulander C, Florea I, Huusom AK,. 2006. Prevention of relapse in generalized anxiety disorder by escitalopram treatment. Int J Neuropsychopharmacol 9: 495-505. (Pubitemid 44607202)
2. Arce E, Simmons AN, Lovero KL, Stein MB, Paulus MP,. 2008. Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology (Berl) 196: 661-672.
3. Association AP,. 2000. Diagnostic and Statistical Manual for Mental Disorders (4th edn, test revision). American Psychiatric Association: Washinton DC.
4. Beekman AT, Bremmer MA, Deeg DJ, et al,. 1998. Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam. Int J Geriatr Psychiatry 13: 717-726. (Pubitemid 28491262)
5. Beekman AT, Deeg DJ, Braam AW, Smit JH, Van Tilburg W,. 1997. Consequences of major and minor depression in later life: a study of disability, well-being and service utilization. Psychol Med 27: 1397-1409. (Pubitemid 27494105)
6. Benitez CI, Smith K, Vasile RG, et al,. 2008. Use of benzodiazepines and selective serotonin reuptake inhibitors in middle-aged and older adults with anxiety disorders: a longitudinal and prospective study. Am J Geriatr Psychiatry 16: 5-13.
7. Blackburn IM, Moore RG,. 1997. Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression. Br J Psychiatry 171: 328-334. (Pubitemid 27441553)
8. Blank S, Lenze EJ, Mulsant BH, et al,. 2006. Outcomes of late-life anxiety disorders during 32 weeks of citalopram treatment. J Clin Psychiatry 67: 468-472.
9. Bockting CL, Schene AH, Spinhoven P, et al,. 2005. Preventing relapse/recurrence in recurrent depression with cognitive therapy: a randomized controlled trial. J Consult Clin Psychol 73: 647-657. (Pubitemid 41368393)
10. Butler AC, Chapman JE, Forman EM, Beck AT,. 2006. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev 26: 17-31. (Pubitemid 41803609)
11. Chou KL,. 2009. Age at onset of generalized anxiety disorder in older adults. Am J Geriatr Psychiatry 17: 455-464.
12. de Beurs E, Beekman AT, van Balkom AJ, et al,. 1999. Consequences of anxiety in older persons: its effect on disability, well-being and use of health services. Psychol Med 29: 583-593. (Pubitemid 29261346)
13. Diefenbach GJ, Stanley MA, beck JG, Novy DM, Averill P,. 2001. Examination of the Hamilton Scales in assessment of anxious older adults: a replication and extension. J Psychopathol Behav Assess 23: 117-124. (Pubitemid 33745848)
14. Fava GA, Park SK, Sonino N,. 2006. Treatment of recurrent depression. Expert Rev Neurother 6: 1735-1740. (Pubitemid 44904017)
15. Fava GA, Ruini C, Rafanelli C,. 2005. Sequential treatment of mood and anxiety disorders. J Clin Psychiatry 66: 1392-1400. (Pubitemid 41779537)
16. First MB, Spitzer RL, Gibbon M, (eds). 1996. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID), Clinician Version: Administration Booklet. American Psychiatric Press: Washington, DC.
17. Folstein MF, Folstein SE, McHugh PR,. 1975. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
18. Gray SL, LaCroix AZ, Hanlon JT, et al,. 2006. Benzodiazepine use and physical disability in community-dwelling older adults. J Am Geriatr Soc 54: 224-230.
19. Gum AM, King-Kallimanis B, Kohn R,. 2009. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication. Am J Geriatr Psychiatry 17: 769-781.
20. Hamilton M,. 1959. The assessment of anxiety states by rating. Br J Med Psychol 32: 50-55.
21. Hofmann SG, Sawyer AT, Korte KJ, Smits JA,. 2009. Is it beneficial to add pharmacotherapy to cognitive-behavioral therapy when treating anxiety disorders? A meta-analytic review. Int J Cogn Ther 2: 160-175.
22. Hollon SD, DeRubeis RJ, Shelton RC, et al,. 2005. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry 62: 417-422. (Pubitemid 40471691)
23. Koepke HH, Gold RL, Linden ME, Lion JR, Rickels K,. 1982. Multicenter controlled study of oxazepam in anxious elderly outpatients. Psychosomatics 23: 641-645. (Pubitemid 12048588)
24. Le Roux H, Gatz M, Wetherell JL,. 2005. Age at onset of generalized anxiety disorder in older adults. Am J Geriatr Psychiatry 13: 23-30. (Pubitemid 41031112)
25. Lenze EJ, Mulsant BH, Mohlman J, et al,. 2005. Generalized anxiety disorder in late life: lifetime course and comorbidity with major depressive disorder. Am J Geriatr Psychiatry 13: 77-80. (Pubitemid 41031118)
26. Lenze EJ, Rollman BL, Shear MK, et al,. 2009. Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial. JAMA 301: 295-303.
27. Lenze EJ, Wetherell JL,. 2009. Bringing the bedside to the bench, and then to the community: a prospectus for intervention research in late-life anxiety disorders. Int J Geriatr Psychiatry 24: 1-14.
28. Ma SH, Teasdale JD,. 2004. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol 72: 31-40. (Pubitemid 38380527)
29. Mantella RC, Butters MA, Amico JA, et al,. 2008. Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder. Psychoneuroendocrinology 33: 773-781.
30. McHugh RK, Barlow DH,. 2010. The dissemination and implementation of evidence-based psychological treatments. A review of current efforts. Am Psychol 65: 73-84.
31. McNally RJ,. 2007. Mechanisms of exposure therapy: how neuroscience can improve psychological treatments for anxiety disorders. Clin Psychol Rev 27: 750-759. (Pubitemid 46899294)
32. Meyer TJ, Miller ML, Metzger RL, Borkovec TD,. 1990. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther 28: 487-495.
33. Miller MD, Paradis CF, Houck PR, et al,. 1992. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 41: 237-248.
34. Pariente A, Dartigues JF, Benichou J, et al,. 2008. Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging 25: 61-70.
35. Paterniti S, Alperovitch A, Ducimetiere P, et al,. 1999. Anxiety but not depression is associated with elevated blood pressure in a community group of French elderly. Psychosom Med 61: 77-83. (Pubitemid 29071849)
36. Paykel ES, Scott J, Cornwall PL, et al,. 2005. Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial. Psychol Med 35: 59-68. (Pubitemid 40201916)
37. Porensky EK, Dew MA, Karp JF, et al,. 2009. The burden of late-life generalized anxiety disorder: effects on disability, health-related quality of life, and healthcare utilization. Am J Geriatr Psychiatry 17: 473-482.
38. Rubio G, Lopez-Ibor JJ,. 2007. Generalized anxiety disorder: a 40-year follow-up study. Acta Psychiatr Scand 115: 372-379. (Pubitemid 46570059)
39. Schoevers RA, Beekman AT, Deeg DJ, Jonker C, van Tilburg W,. 2003. Comorbidity and risk-patterns of depression, generalised anxiety disorder and mixed anxiety-depression in later life: results from the AMSTEL study. Int J Geriatr Psychiatry 18: 994-1001. (Pubitemid 37479371)
40. Schuurmans J, Comijs H, Emmelkamp PM, et al,. 2006. A randomized, controlled trial of the effectiveness of cognitive-behavioral therapy and sertraline versus a waitlist control group for anxiety disorders in older adults. Am J Geriatr Psychiatry 14: 255-263.
41. Schuurmans J, Comijs H, Emmelkamp PM, et al,. 2009. Long-term effectiveness and prediction of treatment outcome in cognitive behavioral therapy and sertraline for late-life anxiety disorders. Int Psychogeriatr 21: 1148-1159.
42. Sinoff G, Werner P,. 2003. Anxiety disorder and accompanying subjective memory loss in the elderly as a predictor of future cognitive decline. Int J Geriatr Psychiatry 18: 951-959. (Pubitemid 37294857)
43. Stanley MA, Wilson NL, Novy DM, et al,. 2009. Cognitive behavior therapy for generalized anxiety disorder among older adults in primary care: a randomized clinical trial. JAMA 301: 1460-1467.
44. Trollor JN, Anderson TM, Sachdev PS, Brodaty H, Andrews G,. 2007. Prevalence of mental disorders in the elderly: the Australian National Mental Health and Well-Being Survey. Am J Geriatr Psychiatry 15: 455-466.
45. Unutzer J, Katon W, Callahan CM, et al,. 2002. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA 288: 2836-2845. (Pubitemid 35425069)
46. Wetherell JL, Ayers CR, Sorrell JT, et al,. 2009. Modular psychotherapy for anxiety in older primary care patients. Am J Geriatr Psychiatry 17: 483-492.
47. Wetherell JL, Thorp SR, Patterson TL, et al,. 2004. Quality of life in geriatric generalized anxiety disorder: a preliminary investigation. J Psychiatr Res 38: 305-312. (Pubitemid 38299168)
48. Wilkinson P, Alder N, Juszczak E, et al,. 2009. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. Int J Geriatr Psychiatry 24: 68-75.
49. Wright RM, Roumani YF, Boudreau R, et al,. 2009. Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging And Body Composition Study. J Am Geriatr Soc 57: 243-250.